Skip to main content
PURE Bioscience, Inc. (PURE)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
At close: Nov 13, 2026

PURE Bioscience Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Net Income
-2.48-2.4-3.35-3.96-3.49
Depreciation & Amortization
000.150.120.21
Asset Writedown & Restructuring Costs
--0.060.320.35
Stock-Based Compensation
0.20.150.210.320.57
Other Operating Activities
---0.03-0.16
Change in Accounts Receivable
0.14-0.18-0.01-0.080.17
Change in Inventory
-0.05-0.090.030.060.08
Change in Accounts Payable
0.050.210.2-0.04-0.16
Change in Other Net Operating Assets
0.410.290.18-0.040.01
Operating Cash Flow
-1.74-2.02-2.53-3.28-2.42
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Capital Expenditures
----0.03-0.08
Investing Cash Flow
----0.03-0.08

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Long-Term Debt Issued
0.9721.791.02-
Total Debt Issued
0.9721.791.02-
Net Debt Issued (Repaid)
0.9721.791.02-
Issuance of Common Stock
1---3.5
Financing Cash Flow
1.9721.791.023.5

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Net Cash Flow
0.24-0.02-0.75-2.31

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Free Cash Flow
-1.74-2.02-2.53-3.31-2.5
Free Cash Flow Growth
-----
Free Cash Flow Margin
-74.98%-91.51%-128.94%-176.40%-134.86%
Free Cash Flow Per Share
-0.01-0.02-0.02-0.03-0.03
Levered Free Cash Flow
-1.21-1.51-1.44-1.95-1.23
Unlevered Free Cash Flow
-0.95-1.32-1.34-1.94-1.23

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Cash Income Tax Paid
0.0100.010.010
Change in Working Capital
0.550.240.4-0.110.1